Atomo Diagnostics Statistics

Total Valuation

Atomo Diagnostics has a market cap or net worth of AUD 12.14 million. The enterprise value is 8.54 million.

Market Cap	12.14M
Enterprise Value	8.54M

Important Dates

The next estimated earnings date is Thursday, January 30, 2025.

Earnings Date	Jan 30, 2025
Ex-Dividend Date	n/a

Share Statistics

Atomo Diagnostics has 639.20 million shares outstanding. The number of shares has increased by 11.17% in one year.

Current Share Class	n/a
Shares Outstanding	639.20M
Shares Change (YoY)	+11.17%
Shares Change (QoQ)	+1.85%
Owned by Insiders (%)	9.50%
Owned by Institutions (%)	n/a
Float	305.45M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	2.95
PB Ratio	1.20
P/TBV Ratio	1.37
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-1.25
EV / Sales	2.09
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-1.82

Financial Position

The company has a current ratio of 6.39, with a Debt / Equity ratio of 0.01.

Current Ratio	6.39
Quick Ratio	4.84
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	-0.02
Interest Coverage	-699.45

Financial Efficiency

Return on equity (ROE) is -55.06% and return on invested capital (ROIC) is -33.01%.

Return on Equity (ROE)	-55.06%
Return on Assets (ROA)	-29.88%
Return on Capital (ROIC)	-33.01%
Revenue Per Employee	48,077
Profits Per Employee	-80,562
Employee Count	85
Asset Turnover	0.29
Inventory Turnover	1.33

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -13.64% in the last 52 weeks. The beta is 0.97, so Atomo Diagnostics's price volatility has been similar to the market average.

Beta (5Y)	0.97
52-Week Price Change	-13.64%
50-Day Moving Average	0.02
200-Day Moving Average	0.02
Relative Strength Index (RSI)	43.42
Average Volume (20 Days)	287,691

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Atomo Diagnostics had revenue of AUD 4.09 million and -6.85 million in losses. Loss per share was -0.01.

Revenue	4.09M
Gross Profit	1.44M
Operating Income	-6.66M
Pretax Income	-6.85M
Net Income	-6.85M
EBITDA	-5.42M
EBIT	-6.66M
Loss Per Share	-0.01

Full Income Statement

Balance Sheet

The company has 3.69 million in cash and 84,670 in debt, giving a net cash position of 3.60 million or 0.01 per share.

Cash & Cash Equivalents	3.69M
Total Debt	84,670
Net Cash	3.60M
Net Cash Per Share	0.01
Equity (Book Value)	10.08M
Book Value Per Share	0.02
Working Capital	6.40M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -4.69 million and capital expenditures -16,084, giving a free cash flow of -4.70 million.

Operating Cash Flow	-4.69M
Capital Expenditures	-16,084
Free Cash Flow	-4.70M
FCF Per Share	-0.01

Full Cash Flow Statement

Margins

Gross margin is 35.16%, with operating and profit margins of -162.94% and -167.57%.

Gross Margin	35.16%
Operating Margin	-162.94%
Pretax Margin	-167.57%
Profit Margin	-167.57%
EBITDA Margin	-132.72%
EBIT Margin	-162.94%
FCF Margin	n/a

Dividends & Yields

Atomo Diagnostics does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-11.17%
Shareholder Yield	-11.17%
Earnings Yield	-56.78%
FCF Yield	-38.72%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Atomo Diagnostics has an Altman Z-Score of -0.18. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.18
Piotroski F-Score	n/a